Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Language
Publication year range
1.
Front Immunol ; 13: 769900, 2022.
Article in English | MEDLINE | ID: mdl-35185875

ABSTRACT

The novel SARS-CoV-2 coronavirus infection has become a global health concern, causing the COVID-19 pandemic. The disease symptoms and outcomes depend on the host immunity, in which the human leukocyte antigen (HLA) molecules play a distinct role. The HLA alleles have an inter-population variability, and understanding their link to the COVID-19 in an ethnically distinct population may contribute to personalized medicine. The present study aimed at detecting associations between common HLA alleles and COVID-19 susceptibility and severity in Armenians. In 299 COVID-19 patients (75 asymptomatic, 102 mild/moderate, 122 severe), the association between disease severity and classic HLA-I and II loci was examined. We found that the advanced age, male sex of patients, and sex and age interaction significantly contributed to the severity of the disease. We observed that an age-dependent effect of HLA-B*51:01 carriage [odds ratio (OR)=0.48 (0.28-0.80), Pbonf <0.036] is protective against severe COVID-19. Contrary, the HLA-C*04:01 allele, in a dose-dependent manner, was associated with a significant increase in the disease severity [OR (95% CI) =1.73 (1.20-2.49), Pbonf <0.021] and an advancing age (P<0.013). The link between HLA-C*04:01 and age was secondary to a stronger association between HLA-C*04:01 and disease severity. However, HLA-C*04:01 exerted a sex-dependent differential distribution between clinical subgroups [females: P<0.0012; males: P=0.48]. The comparison of HLA-C*04:01 frequency between subgroups and 2,781 Armenian controls revealed a significant incidence of HLA-C*04:01 deficiency in asymptomatic COVID-19. HLA-C*04:01 homozygous genotype in patients blueprinted a decrease in heterozygosity of HLA-B and HLA class-I loci. In HLA-C*04:01 carriers, these changes translated to the SARS-CoV-2 peptide presentation predicted inefficacy by HLA-C and HLA class-I molecules, simultaneously enhancing the appropriate HLA-B potency. In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. Based on our observations, we developed a prediction model involving demographic variables and HLA-C*04:01 allele for the identification of potential cases with the risk of hospitalization (the area under the curve (AUC) = 86.2%) or severe COVID-19 (AUC =71%).


Subject(s)
COVID-19/pathology , HLA-B51 Antigen/genetics , HLA-C Antigens/genetics , SARS-CoV-2/immunology , Severity of Illness Index , Adult , Age Factors , Armenia , Female , Gene Frequency/genetics , HLA-B51 Antigen/immunology , HLA-C Antigens/immunology , Heterozygote , Histocompatibility Antigens Class I/genetics , Humans , Male , Middle Aged , Pandemics , Risk , Sex Factors , Viral Proteins/immunology
2.
Health Systems in Transition, vol. 8 (6)
Article in English | WHO IRIS | ID: who-107804

ABSTRACT

The Health Systems in Transition (HiT) profiles are country-based reports that provide a detailed description of a health system and of policy initiatives in progress or under development. HiTs examine different approaches to the organization, financing and delivery of health services and the role of the main actors in health systems; describe the institutional framework, process, content and implementation of health and health care policies; and highlight challenges and areas that require more in-depth analysis. Since independence, the health system in Armenia has undergone numerous changes that have effectively transformed a centrally run state system into a fragmented one that is largely financed from out-of-pocket payments. The population, especially those in need, meet with limited access to health services, and those services which are available are often of questionable quality, as health care standards and quality assessment systems are absent. Drugs on the essential drugs list are generally not affordable to those in need. Many health facilities, especially in rural areas, lack modern medical technology and what is available is not distributed efficiently. The commitment to free health care thus remains more declarative than factual, as informal payments are still expected in many cases. Despite significant investments in primary care, a disproportionate share of resources has been invested in secondary and tertiary care. Nevertheless, Armenia is increasingly engaged in reforming the system from one that emphasizes the treatment of diseases and response to epidemics towards a system that emphasizes prevention, family care and community participation. The shift towards a primary care orientation is noticeable, with gradually increased roles for health workers to influence the determinants of health.


Subject(s)
Delivery of Health Care , Evaluation Study , Healthcare Financing , Health Care Reform , Health Systems Plans , Armenia
SELECTION OF CITATIONS
SEARCH DETAIL
...